NCT00662298View on ClinicalTrials.gov

Prednisolone Pharmacokinetics in Severe Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Asthma
Interventions
DRUG

prednisolone

40mg of prednisolone once a day for 14 days

Trial Locations (1)

SW3 6LY

Asthma Laboratory, Royal Brompton Hospital, London

All Listed Sponsors
collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

lead

Imperial College London

OTHER

NCT00662298 - Prednisolone Pharmacokinetics in Severe Asthma | Biotech Hunter | Biotech Hunter